How much funding has Comet Bio raised?

Comet Bio has raised $27.0M in total funding, most recently a Series C round.

Who are Comet Bio's investors?

Comet Bio's investors include Sofinnova Partners, Open Prairie, Louis Dreyfus Company, BDC Venture Capital.

Where is Comet Bio headquartered?

Comet Bio is headquartered in London, Canada.

What industry is Comet Bio in?

Comet Bio operates in Biotech, Clean Tech, Food and Beverage.

Comet Bio

Award-winning food ingredients company

London, Canada · Founded 2009 · $27.0M raised

Biotech

Clean Tech

Food and Beverage

Headquarters: London
Employees: 11–50
Founded: 2009
Business Model: B2B

Website: comet-bio.com
Total Funding: $27.0M
Last Round: $22.0M Series CJul 2021
Rounds: 2

About

Comet Bio upcycles agricultural crop residues — primarily wheat straw — into Arrabina®, a proprietary line of arabinoxylan prebiotic dietary fiber ingredients for food, beverage, and supplement brands. The company uses patented biorefinery technology to extract high-quality soluble fiber from materials otherwise discarded in food production. Comet operates facilities in London, Ontario and Schaumburg, Illinois, with manufacturing partnership in Denmark.

Summary

Comet Bio is a Biotech company based in London, Canada, founded in 2009. It has raised $27.0M in total across 2 rounds, most recently a $22.0M Series C round in Jul 2021. Investors include Sofinnova Partners, Open Prairie and Louis Dreyfus Company.

LinkedIn X (Twitter)